[Can lorazepam be distinguished from other short-acting benzodiazepines in regard to brain damage and withdrawal symptoms?]

Ned Tijdschr Geneeskd. 1981 Jan 24;125(4):156.
[Article in Dutch]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Anxiety Agents / adverse effects*
  • Humans
  • Lorazepam / adverse effects*
  • Substance Withdrawal Syndrome*
  • Substance-Related Disorders*

Substances

  • Anti-Anxiety Agents
  • Lorazepam